Skip to main content
. 2017 Apr 5;5(2):e124–e130. doi: 10.1016/j.esxm.2017.02.001

Table 2.

Treatment-emergent AEs reported in more than 5% of patients (intent-to-treat population)

Preferred term N = 189, n (%)
Any AE 182 (96.3)
Penile hematoma 114 (60.3)
Penile pain 64 (33.9)
Penile swelling 57 (30.2)
Penile edema 46 (24.3)
Penile hemorrhage 39 (20.6)
Injection-site hematoma 35 (18.5)
Injection-site pain 32 (16.9)
Injection-site hemorrhage 21 (11.1)
Injection-site swelling 20 (10.6)
Contusion 17 (9.0)

AE = adverse event.

Most (95.9%) were identified as bruising.